Showing results (1241-1250 of 1,420) with videos related to

Sort By:
Pageof 142
Journal of Hepatology|January 15, 2018
Hsp72 protects against liver injury via attenuation of hepatocellular death, oxidative stress, and JNK signalingKateryna Levada, Nurdan Guldiken, Xiaoji Zhang, et al.
Heliyon|October 16, 2023
SARS-CoV-2 mutations affect antigen processing by the proteasome to alter CD8<sup>+</sup> T cell responsesDannielle Wellington, Zixi Yin, Zhanru Yu, et al.
Plos Genetics|October 19, 2018
Identification of UHRF2 as a novel DNA interstrand crosslink sensor proteinAnna Motnenko, Chih-Chao Liang, Di Yang, et al.
Molecular Cell|September 4, 2016
SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC SignalingPaul R Elliott, Derek Leske, Matous Hrdinka, et al.
European Urology|December 5, 2008
Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatmentAlexander Roosen, Soumendra N Datta, Rasheda A Chowdhury, et al.
NAR Molecular Medicine|July 13, 2026
HyperTRIBE identifies hepatic IGF2BP2/IMP2 targets <i>in vivo</i> and links IMP2 to autophagyHoang Thu Trang Do, Simon Both, Tarek Kröhler, et al.
Plos Medicine|June 22, 2016
Prediction of Bladder Outcomes after Traumatic Spinal Cord Injury: A Longitudinal Cohort StudyChiara Pavese, Marc P Schneider, Martin Schubert, et al.
Radiology|September 1, 1982
Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brainN J Patronas, G Di Chiro, R A Brooks, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 26, 2015
Using an Integrated -Omics Approach to Identify Key Cellular Processes That Are Disturbed in the Kidney After Brain DeathM Z Akhtar, H Huang, M Kaisar, et al.
British Journal of Haematology|December 18, 2012
Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study)Jeffrey I Zwicker, Howard A Liebman, Kenneth A Bauer, et al.
Pageof 142